A Cataract Surgery Clinical Trial
Key facts
- Who runs it
- Alcon Research
- Where
- Salt Lake City, Sioux Falls, Spring, Sugar Land, and West Des Moines, United StatesSee the 5 sites
- Trial code
- Status
- Withdrawn
- Started
- Feb 2026
- Ended
- Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- UNITY Vitreoretinal Cataract System
- CENTURION Vision System with Active Sentry
- Anterior segment ophthalmic surgery
- Record updated
- 12 December 2025
- Why it stopped
- Sponsor's business decision based on strategic shifts
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Clinically documented diagnosis of age-related nuclear sclerotic cataract of grade 2 or greater in both eyes
- Both eyes with similar nuclear sclerotic cataract severity and type (within 1 cataract grade)
- Both eyes able to be implanted with same intraocular lens material
- Both eyes able to receive the same ophthalmic viscosurgical device (OVD)
- Other protocol-specified inclusion criteria may apply
Who cannot take part
- Planned intraoperative glaucoma surgery or expected postoperative procedures during the study in either study eye
- Laser-assisted cataract surgery in either study eye
- Any ocular disease and/or condition that, in the investigator's clinical judgement, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study
- Other protocol-specified exclusion criteria may apply
Where in United States
- The Eye Institute of UtahSalt Lake City, United States
- Vance Thompson VisionSioux Falls, United States
- Whitsett Vision GroupSpring, United States
- Berkeley Eye CenterSugar Land, United States
- Wolfe Eye ClinicWest Des Moines, United States
About the trial
What the trial wants to find out
The purpose of the study is to compare the efficiency and safety of UNITY™ Vitreoretinal Cataract System (UNITY VCS) to CENTURION® Vision System with Active Sentry (CAS) in adult subjects with grade 2 or greater nuclear sclerotic cataracts who require phacoemulsification in both eyes. Subjects will attend a total of 8 scheduled visits for an individual duration of participation of approximately 1 month.
The 2 groups in the trial
- UNITY Vitreoretinal Cataract System (VCS)Treatment being tested
Anterior segment ophthalmic surgery in one eye using UNITY Vitreoretinal Cataract System (VCS)
Treatment: UNITY Vitreoretinal Cataract System and Anterior segment ophthalmic surgery
- CENTURION Vision System with Active Sentry (CAS)Existing treatment, for comparison
Anterior segment ophthalmic surgery in one eye using CENTURION Vision System with Active Sentry (CAS)
Treatment: CENTURION Vision System with Active Sentry and Anterior segment ophthalmic surgery
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Cataract Surgery: Randomized Comparative Clinical Trial
- Record updated
- 12 December 2025